Compass Therapeutics to PresentÂ at the 2022 Jefferies Global Healthcare Conference
globenewswire.com
news
2022-05-31 00:00:00

BOSTON, May 31, 2022 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage biopharmaceutical company developing proprietary antibody-based therapeutics to treat cancer, today announced it will present at the 2022 Jefferies Global Healthcare Conference that will be held in New York City on Thursday, June 9, 2022, at 8:00 am ET. About Compass Therapeutics Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases.
